These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 28984649
1. Orthostatic hypotension for the cardiologist. Mar PL, Raj SR. Curr Opin Cardiol; 2018 Jan; 33(1):66-72. PubMed ID: 28984649 [Abstract] [Full Text] [Related]
2. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension. Olshansky B, Muldowney J. Am J Cardiol; 2020 May 15; 125(10):1582-1593. PubMed ID: 32204870 [Abstract] [Full Text] [Related]
3. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Isaacson SH, Skettini J. Vasc Health Risk Manag; 2014 May 15; 10():169-76. PubMed ID: 24729712 [Abstract] [Full Text] [Related]
4. New developments in the management of neurogenic orthostatic hypotension. Biaggioni I. Curr Cardiol Rep; 2014 Nov 15; 16(11):542. PubMed ID: 25303896 [Abstract] [Full Text] [Related]
6. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol. Patrick K, Martin T. JBI Database System Rev Implement Rep; 2017 Sep 15; 15(9):2287-2294. PubMed ID: 28902695 [Abstract] [Full Text] [Related]
8. Chemical pharmacotherapy for the treatment of orthostatic hypotension. Cheshire WP. Expert Opin Pharmacother; 2019 Feb 15; 20(2):187-199. PubMed ID: 30376728 [Abstract] [Full Text] [Related]
17. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report. Ho AH, Kinter CW, Wight J, Neelam AR, Krakow D. J Med Case Rep; 2020 Jun 20; 14(1):73. PubMed ID: 32560740 [Abstract] [Full Text] [Related]